Bill > SB237

This bill aims to enhance the tracking and sale of pseudoephedrine products, which are commonly used in the manufacture of illegal drugs. The key provisions include: 1. Requiring sellers to record specific details about the purchase of pseudoephedrine products, such as the purchaser's name, address, date of birth, and the quantity and type of product purchased. The purchaser and seller must both sign the record of the transaction. 2. Establishing an electronic system called the National Precursor Log Exchange (NPLEx) to track pseudoephedrine sales in real-time. Sellers must submit records of sales to this system before completing a transaction, and the system can generate "stop sale alerts" if the purchase would exceed quantity limits. 3. Allowing sellers to override the stop sale alert only if they have a reasonable fear of imminent harm, and providing sellers with immunity from liability if they follow the requirements in good faith. 4. Granting law enforcement officers access to the records of pseudoephedrine sales for use in criminal investigations and prosecutions related to illegal drug manufacturing. The bill aims to combat the use of pseudoephedrine in the production of methamphetamine by implementing a more robust system for monitoring and controlling the sale of these products.